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Abstract: 
The blood, serum & urine samples are collected from (22) patients with urinary bladder cancer were admitted to 
Al-Hilla general teaching hospital after diagnosis by helping urology physician. The result appeared that E.coli 
with high percentage (22.7% ,27.2%)in nixed &single infection respectively followed by Ps.aeuroginosa (22.7% 
, 13.6%) and S.aureus (18.8% , 9.09%).   Interleukin 2 &Interleukin 8 concentration level was detected in serum 
by enzyme-linked immunosorbent assay(ELISA) and data were compared with control to compare the 
performance of each cytokins & results show no elevated , no significant decrease in level  in two cytokins, this 
leads  to an independent factors for the detection of urinary bladder cancer. 
 
Introduction 
 Bladder cancer is the ninth most common cancer diagnosis worldwide, with more than 330 000 new cases each 
year and more than 130 000 deaths per year. (Ploeg  et al., 2009 ; Zhou et al., 2009) 
Bacterial infections traditionally have not been considered major causes of cancer.  Recently, however, bacteria 
have been linked to cancer by two mechanisms: induction of chronic inflammation and production of 
carcinogenic bacterial metabolites. 
One of the etiological factors implicated in the development and progression of bladder cancer includes 
urinary tract infections (UTIs) including bacterial, parasitic, fungal, and viral infections; urinary lithiasis and 
pelvic radiation (Pasin et al., 2008). 
Bacteria are the primary cause of UTIs, with the vast majority (70–80%) attributed specifically to 
infection with Escherichia coli. A recurring theme in the link between bacterial infection and carcinogenesis is 
that of chronic inflammation, which is often a common feature of persistent infection (Karin and  Greten 2005). 
Also Cytokines are important mediators of inflammation and are associated with pathogenesis of many 
inflammatory diseases. ( Shahzad et al., 2010). 
IL-2 signal plays a key role in promoting development, homeostasis and function of regulatory T cells. 
IL-2 affects multiple signal pathways, and its deficiency causes the multifacted dysregulation of immune 
response. (Geng et al., 2012). IL-2 also seems to be associated with the malignancy of the tumour  .Also 
Increased expression of IL-2 and IL-2R has been reported in actively proliferating tumours such as stomach, 
renal and spinocellular cancers , squamous cell carcinomas of the head and neck , melanomas, neuroblastic 
tumours and prostate cancer.( Tuñón et al., 2004).Also Recently, it has been shown that IL-8 plays a critical role 
in cancer invasion, angiogenesis and metastasis. It is a chemotactic factor for T cells, neutrophils, and basophils 
besides its pro-inflammatory role, IL-8 has been evaluated as a pro-oncogenic effector in various types of human 
cancers, including leukemia, astrocytoma, melanoma, breast cancer, ovarian cancer, lung cancer, prostate cancer, 
colon cancer, urinary system cancer , gastric cancer and pancreatic cancer (Mahdi  et al., 2013). IL-8 signaling 
has been shown to induce the activation of this classic Mitogen Activated Protein Kinases (MAPK) signaling 
cascade, with downstream phosphorylation of extracellular signal-regulated kinases (Erk) detected in both 
neutrophils and cancer cells (Luppi et al., 2007). 
Material and Methods: 
Total of 22 patients with Urinary Bladder Carcinoma UBC were admitted to AL- Hilla  General Teaching 
Hospital /Iraq after they diagnosis by helping with Urology Physician were suspected to have UBC according to 
their clinical manifestations and Ultrasound changes. 
Venous blood samples, serum and urine were collected from 22 patients suffering from Urinary Bladder 
Carcinoma, as well as, patients without taking any chemotherapeutic agents.  
The age of the patients are ranging from (45-80) years old including (20 males) and (2 females). Detection 
bacteria by culturing urine on ordinary and specific media and biochemical test for isolation and differentiation.  
The concentration of Interleukin -2 & Interleukin -8 evaluate by using serum from patients and ELISA kits 
(koma biotech-Korea ). 
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Result and Discussion: 
Although, there is no evidence on the role of bacteria in the stimulation of urinary bladder cancer, but some 
patients complain from sever urinary tract infections UTI .So, the present study investigates on the main bacteria 
associated with UTI in patients with urinary bladder cancer.  
 Recently, however, bacteria have been linked to cancer by two mechanisms: induction of chronic inflammation 
and production of carcinogenic bacterial metabolites. The most specific example of the inflammatory mechanism 
of carcinogenesis is Escherichia coli infection. E. coli has been epidemiologically linked to urothelial carcinoma 
of the urinary bladder by its propensity to cause lifelong inflammation ( Gabri et al., 2012).  Also Shokeir A. 
(2004) explained that Bladder carcinogenesis is probably related to bacterial and viral infections, commonly 
associated with bilharzial infestation rather than the parasite itself.  It was observed that E.coli is predominant 
among other bacteria, followed by Pseudomonas and Staphylococcus , The other type of  bacteria includes 
Klebsiella pneumoniae . This finding is in agreement with the study performed by Al-Bayati et al., (2009) that is 
obvious that E. coli is the most predominant organisms followed by K. pneumoniae and Ps. aeruginosa . Also 
El-Mosalamy  et al., (2012) that was showed a history of urinary tract infection can be considered as a risk factor 
for bladder cancer specially infection by E. coli may play a major additive and synergistic role during bladder 
carcinogenesis. 
Table (1) The Bacterial  isolation from urine of patients with urinary bladder cancer 
 
  Mixed Bacterial Isolates 
Total  
Percentage 
% 
Number Bacterial Isolates  
9  
40.9% 
22.7% 5 
Escherichia coli 
+ 
Pseudomonas aeroginosa  
18.18% 4 
Escherichia coli 
+ 
Staphylococcus aureus 
  
Single Bacterial Isolates 
Total 
Percentage 
% 
Number Bacterial Isolates  
13  
59.09% 
27.27% 6 
Escherichia coli 
  
9.09% 2 
Staphylococcus aureus 
  
9.09% 2 Klebsiella Pneumonia  
13.6% 3  Pseudomonas aeroginosa  
 
The present study shows no elevated in IL-8 level and this may be belong to all cases of have superficial but not 
invasive cancer. Alteration of cytokine levels is associated with cancer progression. ( Lin et al., 2004) 
Hikmet et al., (2004) results who revealed a high IL-8 levels which is related to invasive bladder cancer patients 
and not to individuals with superficial bladder cancer .also Mahdi  et al., (2013) show of ELISA test for IL-8 
revealed a significantly increase serum IL-8 of patients with urinary bladder cancer in comparison with control 
group. 
Previous studies have documented elevated of IL-8 in patients with urothelial cell carcinoma and this elevated 
associated with increased stage of disease, disease recurrence and lack of efficacy of intravesical therapies, 
including bacillus Calmette-Guérin and mitomycin C. (Sagnak et al., 2009 ; Kocak et al., 2004). 
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Figure (1) The Interleukin 8 concentration in patients with urinary bladder cancer comparing with 
control. P 0.005048 
 
Recently, it has been shown that IL-8 plays a critical role in cancer invasion, angiogenesis and metastasis. It is a 
chemotactic factor for T cells, neutrophils, and basophils besides its pro-inflammatory role, IL-8 has been 
evaluated as a pro-oncogenic effector in various types of human cancers, including leukemia, astrocytoma, 
melanoma, breast cancer, ovarian cancer, lung cancer, prostate cancer, colon cancer, urinary system cancer , 
gastric cancer and pancreatic cancer.( Kuwada et al., 2003; Utgaard et al., 1998). 
Also Decrease IL-2 in serum of patients with urinary bladder cancer might be show refer to that the lower 
immune system that maintains or regulated tumor activity against malignant bladder tissue. However interleukin-
2 (IL-2) may boost the immune system to fight tumors and IL-2 plays a pivotal role in the treatment of patients 
with metastatic melanoma and renal cell carcinoma. ( Liang et al., 2012). 
This finding has led to some authors to conclude that whereas endogenous IL-2 stimulates cell proliferation, 
exogenous IL-2 inhibits such a proliferation (Reichert et al., 2000). 
 
Figure (2) The Interleukin 2 concentration in Patients with urinary bladder cancer comparing with 
control . P 0.003378 
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